Browsing Category

Top Industry News

7428 posts

The DCAT Summit at Lugano Recap: Serving Patients through Agility and Innovation in Development and Manufacturing 
By

By
At the DCAT Summit at Lugano, “Expedition Pharma: Innovation from a Patient-First Perspective,” held June 4–5, 2025, in Lugano, Switzerland, pharmaceutical leaders emphasized that agility and innovation are not optional—they…

AstraZeneca Investing $4.5-Bn in New API US Mfg Facility  
By

By
AstraZeneca has announced the location of a new $4.5-billion active pharmaceutical ingredient (API) manufacturing facility in Charlottesville, Albemarle County, Virginia, which will support manufacturing over a broad range of medicines,…

Other US Mfg News: AbbVie Breaks Ground on $195-M API Facility; Lupin Investing $250 M in Florida 
By

By
AbbVie breaks ground on new $195-M API manufacturing facility AbbVie has announced the start of construction of a new $195-million active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois. The…

Merck & Co. Completes $10-Bn Acquisition of Verona Pharma 
By

By
Merck & Co. has completed its $10-billion acquisition of Verona Pharma, a bio/pharmaceutical company focused on respiratory diseases, for $10 billion. The deal was announced in July 2025.  Through this…

Novo Nordisk To Acquire Akero Therapeutics in $5.2-Bn Deal  
By

By
Novo Nordisk has agreed to acquire Akero Therapeutics, a South San Franciso, California-based clinical-stage bio/pharma company focused on metabolic diseases, including metabolic dysfunction-associated steatohepatitis (MASH), in a deal worth up…

Supplier News: Thermo Fisher, Lonza, MilliporeSigma & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Thermo Fisher Scientific, Lonza, Cytiva, MilliporeSigma, Oxford Biomedica, National Resilience, Siegfried, Celonic, Carbogen Amcis, Asimov, Made Scientific, Syenex, Symbiosis, and Afton Scientific.  …

DCAT Summit at Lugano Recap: Innovation at the Foundation of Pharmaceutical Development & Manufacturing 
By

By
In the race to deliver medicines faster, the industry’s next leap forward is being built—literally—at the ground floor of development and manufacturing. At the DCAT Summit at Lugano, “Expedition Pharma:…

GSK CEO Emma Walmsley Stepping Down; CEO Designate Named 
By

By
GSK has announced that Luke Miels, current Chief Commercial Officer at GSK, has been appointed CEO Designate, succeeding Emma Walmsley, who will step down as CEO, effective at the end…

Amgen Investing $650 M To Expand Mfg in Puerto Rico 
By

By
Amgen has announced a $650-million expansion of the company’s biologics manufacturing facility in Juncos, Puerto Rico, the latest of a series of investments in the US.   In September (September 2025),…

AbbVie Breaks Ground on $70-M US Biologics R&D & Mfg Expansion 
By

By
AbbVie has announced the start of construction of a $70-million expansion at the AbbVie Bioresearch Center in Worcester, Massachusetts, which serves as a center of excellence for biologics research and…